Nepal recently announced that the second phase of its coronavirus vaccination drive will begin from Wednesday, using China-made Vero Cell vaccine manufactured by the Beijing Institute of Biological Products in February this year.
Nepal has granted emergency approval to the Chinese Vero Cell vaccine, given the active caseload that stands at 277,944 on Monday, while 273,240 people have recovered in Nepal.
On March 29, a batch of the Chinese Covid-19 vaccines developed by Sinopharm was delivered to Nepal.
On Sunday, Nepal s Ministry of Health and Population made the announcement where it hinted that at least 4,00,000 people will be initially vaccinated using the Chinese drug for Covid-19.